Finance

Lists
WOCKPHARMA:NSE
Wockhardt Ltd
1 980,00 INR
-0,16%
(-3,10) 1D
14 ოქტ, 15:30:03 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for WOCKPHARMA...
Open
1 986,00 INR
High
2 003,90 INR
Low
1 960,40 INR
Mkt. cap
321,73 მლრ.
Avg. vol.
1,20 მლნ.
Volume
483,87 ათ.
P/E ratio
78,65
52-wk high
2 422,30 INR
52-wk low
1 086,70 INR
EPS
25,17 INR
Shares outstanding
110,69 მლნ.
No. of employees
3 ათ.
Open
1 986,00 INR
High
2 003,90 INR
Low
1 960,40 INR
Mkt. cap
321,73 მლრ.
Avg. vol.
1,20 მლნ.
Volume
483,87 ათ.
P/E ratio
78,65
52-wk high
2 422,30 INR
52-wk low
1 086,70 INR
EPS
25,17 INR
Shares outstanding
110,69 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOმურთაზა ხორაქივალა
Employees2,56 ათ.
Founded1967
Headquarters-
SectorPharmaceutical industry
Last report
10 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
9,29 მლრდ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
7,82 მლრდ.
8,88 მლრდ.
10,54 მლრდ.
9,29 მლრდ.
Cost of goods sold
2,33 მლრდ.
3,17 მლრდ.
4,03 მლრდ.
3,20 მლრდ.
Cost of revenue
2,33 მლრდ.
3,17 მლრდ.
4,03 მლრდ.
3,20 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,86 მლრდ.
1,81 მლრდ.
1,90 მლრდ.
2,03 მლრდ.
Operating expense
4,42 მლრდ.
4,63 მლრდ.
4,19 მლრდ.
4,76 მლრდ.
Total operating expenses
6,75 მლრდ.
7,80 მლრდ.
8,22 მლრდ.
7,96 მლრდ.
Operating income
1,07 მლრდ.
1,08 მლრდ.
2,32 მლრდ.
1,33 მლრდ.
Other non operating income
210,00 მლნ.
250,00 მლნ.
-710,00 მლნ.
310,00 მლნ.
EBT including unusual items
910,00 მლნ.
670,00 მლნ.
1,89 მლრდ.
1,16 მლრდ.
EBT excluding unusual items
910,00 მლნ.
770,00 მლნ.
1,52 მლრდ.
1,16 მლრდ.
Income tax expense
90,00 მლნ.
60,00 მლნ.
250,00 მლნ.
90,00 მლნ.
Effective tax rate
9,89%
8,96%
13,23%
7,76%
Other operating expenses
2,03 მლრდ.
2,17 მლრდ.
1,76 მლრდ.
2,18 მლრდ.
Net income
780,00 მლნ.
590,00 მლნ.
1,66 მლრდ.
1,06 მლრდ.
Net profit margin
9,97%
6,64%
15,75%
11,41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
70,00 მლნ.
-
Interest expense
-550,00 მლნ.
-600,00 მლნ.
-450,00 მლნ.
-520,00 მლნ.
Net interest expenses
-550,00 მლნ.
-600,00 მლნ.
-380,00 მლნ.
-520,00 მლნ.
Depreciation and amortization charges
530,00 მლნ.
650,00 მლნ.
530,00 მლნ.
550,00 მლნ.
EBITDA
1,62 მლრდ.
1,47 მლრდ.
2,74 მლრდ.
1,74 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები